Advertisement

Table of Contents

May 01, 1993; Volume 43,Issue 5

You have access
Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells.
D Krautwurst, J Hescheler, D Arndts, W Lösel, R Hammer and G Schultz

Molecular Pharmacology May 1993, 43 (5) 655-659;
You have access
Isolation and expression of a cDNA coding for rat kidney cytosolic cysteine conjugate beta-lyase.
S J Perry, M A Schofield, M MacFarlane, E A Lock, L J King, G G Gibson and P S Goldfarb

Molecular Pharmacology May 1993, 43 (5) 660-665;
You have access
Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
V A Boundy, R R Luedtke, R P Artymyshyn, T M Filtz and P B Molinoff

Molecular Pharmacology May 1993, 43 (5) 666-676;
You have access
Photoaffinity labeling of subtype 2 angiotensin receptor of human myometrium.
G Servant, G Boulay, R Bossé, E Escher and G Guillemette

Molecular Pharmacology May 1993, 43 (5) 677-683;
You have access
delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
P Y Law and H H Loh

Molecular Pharmacology May 1993, 43 (5) 684-693;
You have access
Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: a comparative polymerase chain reaction study.
M C Steel and N J Buckley

Molecular Pharmacology May 1993, 43 (5) 694-701;
You have access
Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
S T Davis and S H Berger

Molecular Pharmacology May 1993, 43 (5) 702-708;
You have access
Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus.
J L Kirkland, L Murthy and G M Stancel

Molecular Pharmacology May 1993, 43 (5) 709-714;
You have access
Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
P De Isabella, G Capranico, M Palumbo, C Sissi, A P Krapcho and F Zunino

Molecular Pharmacology May 1993, 43 (5) 715-721;
You have access
Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat.
J Kapitulnik and F J Gonzalez

Molecular Pharmacology May 1993, 43 (5) 722-725;
You have access
Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
R C Ferry, C D Unsworth and P B Molinoff

Molecular Pharmacology May 1993, 43 (5) 726-733;
You have access
Subsecond modulation of formyl peptide-linked guanine nucleotide-binding proteins by guanosine 5'-O-(3-thio)triphosphate in permeabilized neutrophils.
R R Neubig and L A Sklar

Molecular Pharmacology May 1993, 43 (5) 734-740;
You have access
Isolation of glucagon antagonists by random molecular mutagenesis and screening.
R A Smith, R Sisk, P Lockhart, S Mathewes, T Gilbert, K Walker and J Piggot

Molecular Pharmacology May 1993, 43 (5) 741-748;
You have access
Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
A Malmberg, D M Jackson, A Eriksson and N Mohell

Molecular Pharmacology May 1993, 43 (5) 749-754;
You have access
A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
M S Choudhary, S Craigo and B L Roth

Molecular Pharmacology May 1993, 43 (5) 755-761;
You have access
Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
S Mantey, H Frucht, D H Coy and R T Jensen

Molecular Pharmacology May 1993, 43 (5) 762-774;
You have access
Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.
M Mimeault, A Fournier, J Féthiere and A De Léan

Molecular Pharmacology May 1993, 43 (5) 775-782;
You have access
Inhalational anesthetic actions on voltage-gated ion currents of bovine adrenal chromaffin cells.
J J Pancrazio, W K Park and C Lynch

Molecular Pharmacology May 1993, 43 (5) 783-794;
You have access
Indomethacin/ibuprofen-like anti-inflammatory agents selectively potentiate the gamma-aminobutyric acid-antagonistic effects of several norfloxacin-like quinolone antibacterial agents on [35S]t-butylbicyclophosphorothionate binding.
R F Squires and E Saederup

Molecular Pharmacology May 1993, 43 (5) 795-800;
You have access
Comparison of interactions of [3H]muscimol, t-butylbicyclophosphoro[35S]thionate, and [3H]flunitrazepam with cloned gamma-aminobutyric acidA receptors of the alpha 1 beta 2 and alpha 1 beta 2 gamma 2 subtypes.
J F Pregenzer, W B Im, D B Carter and D R Thomsen

Molecular Pharmacology May 1993, 43 (5) 801-806;
You have access
Modulation by albumin of neuronal cholinergic sensitivity.
D Gurantz, J F Margiotta, A T Harootunian and V E Dionne

Molecular Pharmacology May 1993, 43 (5) 807-812;
You have access
Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons.
M R Bowlby

Molecular Pharmacology May 1993, 43 (5) 813-819;
You have access
Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels.
S Hering, A Savchenko, C Strübing, M Lakitsch and J Striessnig

Molecular Pharmacology May 1993, 43 (5) 820-826;
You have access
Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver.
A Lemoine, J C Gautier, D Azoulay, L Kiffel, C Belloc, F P Guengerich, P Maurel, P Beaune and J P Leroux

Molecular Pharmacology May 1993, 43 (5) 827-832;